A Distinct Urinary Biomarker Pattern Characteristic of Female Fabry Patients That Mirrors Response to Enzyme Replacement Therapy
Female patients affected by Fabry disease, an X-linked lysosomal storage disorder, exhibit a wide spectrum of symptoms, which renders diagnosis, and treatment decisions challenging. No diagnostic test, other than sequencing of the alpha-galactosidase A gene, is available and no biomarker has been pr...
Main Authors: | Kistler, Andreas D., Siwy, Justyna, Breunig, Frank, Jeevaratnam, Praveen, Scherl, Alexander, Mullen, William, Warnock, David G., Wanner, Christoph, Hughes, Derralynn A., Mischak, Harald, Wüthrich, Rudolf P., Serra, Andreas L. |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115947/ |
Similar Items
-
Correction: Urinary Proteomic Biomarkers for Diagnosis and Risk Stratification of Autosomal Dominant Polycystic Kidney Disease: A Multicentric Study
by: Kistler, Andreas D., et al.
Published: (2013) -
Urinary Proteomic Biomarkers for Diagnosis and Risk Stratification of Autosomal Dominant Polycystic Kidney Disease: A Multicentric Study
by: Kistler, Andreas D., et al.
Published: (2013) -
Fabry disease and incidence of cancer
by: Sarah Bird, et al.
Published: (2017-09-01) -
Toward a consensus in the laboratory diagnostics of Fabry disease - recommendations of a European expert group
by: Gal, Andreas, et al.
Published: (2011) -
Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications
by: Weidemann, F, et al.
Published: (2013)